New online map presents snapshots of osteopor

Osteoporosis is a serious and growing medical problem in Europe, resulting in more than 4.3 million fragility fractures and enormous medical costs of over €56 billion annually. Nevertheless, it remains highly underdiagnosed and undertreated, with an estimated 71% of high-risk European women not receiving prophylactic treatment.

Spotlight issues during preparation world osteoporosis daythe International Osteoporosis Foundation (IOF) has launched a new interactive online map. Scorecard for osteoporosis in Europe (SCOPE 2021) (1,2) This report reviews and describes the current burden of osteoporosis in each of the EU Member States, as well as Switzerland and the UK, and audits key indicators in four areas. policy framework; service delivery; and service uptake. This map provides a snapshot of five key facts and statistics for each of Europe’s 29 countries. Viewers can click through to access his country’s more detailed illustrated fact sheets and comparative scorecards.

New maps enhance existing maps SCOPE 2021 platform We offer overview reports, country fact sheets, slide sets, infographics, and many other resources. Individual European countries and Europe as a whole. Importantly, SCOPE 2021 will enable policy makers to benchmark their country’s osteoporosis burden, service delivery and acceptance relative to other European countries, as well as measure gaps and progress at the country level. .

When the SCOPE 2021 country reports were published earlier this year, IOF Honorary President Professor John Kanis noted significant differences in service delivery and utilization across Europe, also stating: .

“All 29 European countries surveyed by SCOPE 2021 face enormous osteoporosis and fragility fracture burdens, with significant impacts on current and future healthcare budgets. Women aged 75 and over and The number of males is expected to increase by more than 29% and 42% respectively between 2019 and 2034, so the annual number of fractures due to osteoporosis is projected to increase by about +24.8% over this period. Sexual fractures reach 5.34 million per year.”

“These alarming predictions should spur concerted action by all European health authorities.”

Since its launch, the SCOPE 2021 initiative has been highly influential, with findings widely used to advocate for advances in osteoporosis prevention and treatment in various European countries. In particular, the disconcerting result that nearly 15 million high-risk European women remain untreated exposes a huge treatment gap and highlights the urgent need to prioritize osteoporosis prevention and care. certainly suggests.

IOF President Professor Cyrus Cooper said:

“Of the 29 European countries surveyed in the SCOPE 2021 report, only 9 recognize osteoporosis or musculoskeletal diseases as a public health priority. To spur action for prevention, IOF will work alongside Europe-wide strategies to provide coordinated osteoporosis care and reduce the debilitating impact of fractures on individual lives and health systems. We are looking for a national strategy that

The new SCOPE 2021 online map and related resources are available at https://www.osteoporosis.foundation/scope-2021.

###

References:

1. Willers C, Norton N, Harvey NC, Jacobson T, Johansson H, Lorentzon M, McCloskey EV, Borgström F, Kanis JA, and the IOF SCOPE Review Board. Osteoporosis in Europe: Summary of country-specific reports. Arch Osteoporos 17, 23 (2022). https://doi.org/10.1007/s11657-021-00969-8
2. Kanis JA, Norton N, Harvey NC, Jacobson T, Johansson H, Lorentzon M, McCloskey EV, Willers C, Borgström F. SCOPE 2021: A new scorecard for osteoporosis in Europe. Arch Osteoporos 16, 82 (2021). https://doi.org/10.1007/s11657-020-00871-9
3. SCOPE 2021 resources (maps, overview reports, country factsheets, etc.) https://www.osteoporosis.foundation/scope-2021

Overview of SCOPE 2021 and country reports
The mission of the European Osteoporosis Scorecard (SCOPE) project is to raise awareness of osteoporosis care in Europe. SCOPE provides a detailed comparison of the quality of care for osteoporosis in the 27 Member States of the European Union (EU27) with the United Kingdom and Switzerland (referred to as EU27+2). SCOPE is a compilation of key indicators of the burden of osteoporosis and its management in each European Union Member State and is intended to set benchmarks to inform European Union patients, health care providers and policy makers. Draw attention to gaps in the provision of helpful health care. EU. This update of the original SCOPE publication and scorecard compares the original 2010 results with the 2019 data. The new data not only provide a more recent overview, but also a way to compare osteoporosis management within and between EU27 over time. +2 countries. The purpose of developing this scorecard is to promote a balanced and common optimal approach to the management of osteoporosis across EU27+2. All SCOPE resources are available here: https://www.osteoporosis.foundation/scope-2021

About IOF
The International Osteoporosis Foundation (IOF) is the world’s largest non-governmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members include a panel of scientific researchers and 300 patient, medical and research organizations working together to make fracture prevention and healthy mobility a global healthcare priority. increase. https://www.osteoporosis.foundation @iofbonehealth

About World Osteoporosis Day
World Osteoporosis Day (WOD) is marked on October 20th each year to raise awareness for bone health and osteoporosis prevention. This year’s campaign calls on people around the world to take action for bone health and osteoporosis prevention under the banner ‘Step Up for Bone Health’.
http://www.worldosteoporosisday.org #WorldOsteoporosisDay

WOD Official Partners: Amgen, Sunsweet, Zuellig Pharma, Abbott, Pharmanovia, Theramex